Labcorp Holdings Beheer
Beheer criteriumcontroles 4/4
De CEO Labcorp Holdings is Adam Schechter, benoemd in Nov2019, heeft een ambtstermijn van 11.58 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 15.98M, bestaande uit 8.6% salaris en 91.4% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.1% van de aandelen van het bedrijf, ter waarde $ 21.10M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4.3 jaar en 9.7 jaar.
Belangrijke informatie
Adam Schechter
Algemeen directeur
US$16.0m
Totale compensatie
| Percentage CEO-salaris | 8.6% |
| Dienstverband CEO | 5yrs |
| Eigendom CEO | 0.1% |
| Management gemiddelde ambtstermijn | 4.3yrs |
| Gemiddelde ambtstermijn bestuur | 9.7yrs |
Recente managementupdates
Recent updates
Labcorp Holdings Inc.'s (NYSE:LH) Price In Tune With Earnings
Nov 12
Is Labcorp Holdings (NYSE:LH) Using Too Much Debt?
Oct 19When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?
Sep 12Laboratory Corporation: Difficult To Eye Long-Term Compounding Ability
Sep 11Investors Still Waiting For A Pull Back In Labcorp Holdings Inc. (NYSE:LH)
Jul 20Laboratory Corporation: Limited Upside Visibility, Reiterate Hold
Jun 21When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?
Jun 13Here's Why It's Unlikely That Laboratory Corporation of America Holdings' (NYSE:LH) CEO Will See A Pay Rise This Year
May 08Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72
Apr 30Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72
Apr 15Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark
Apr 06Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear
Apr 01Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72
Feb 25We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings
Feb 22An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued
Feb 21Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72
Jan 31Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 30Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72
Jan 15Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio
Jan 05Laboratory Corporation: Multiple Updates, Same Investment Conclusion
Dec 02Laboratory Corp.: Rate On Capital Deployed Contracting, Hold
Sep 14Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea
Jul 05Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts
Jul 04Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?
Jun 23Laboratory Corporation: Predictability Of Cash Flows Less Visible
Jun 21Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?
May 26Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$436m |
| Jun 30 2024 | n/a | n/a | US$450m |
| Mar 31 2024 | n/a | n/a | US$399m |
| Dec 31 2023 | US$16m | US$1m | US$379m |
| Sep 30 2023 | n/a | n/a | US$583m |
| Jun 30 2023 | n/a | n/a | US$677m |
| Mar 31 2023 | n/a | n/a | US$789m |
| Dec 31 2022 | US$15m | US$1m | US$1b |
| Sep 30 2022 | n/a | n/a | US$2b |
| Jun 30 2022 | n/a | n/a | US$2b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$21m | US$1m | US$2b |
| Sep 30 2021 | n/a | n/a | US$3b |
| Jun 30 2021 | n/a | n/a | US$3b |
| Mar 31 2021 | n/a | n/a | US$3b |
| Dec 31 2020 | US$15m | US$1m | US$2b |
| Sep 30 2020 | n/a | n/a | US$845m |
| Jun 30 2020 | n/a | n/a | US$362m |
| Mar 31 2020 | n/a | n/a | US$321m |
| Dec 31 2019 | US$6m | US$208k | US$824m |
| Sep 30 2019 | n/a | n/a | US$755m |
| Jun 30 2019 | n/a | n/a | US$853m |
| Mar 31 2019 | n/a | n/a | US$896m |
| Dec 31 2018 | US$301k | n/a | US$884m |
| Sep 30 2018 | n/a | n/a | US$1b |
| Jun 30 2018 | n/a | n/a | US$1b |
| Mar 31 2018 | n/a | n/a | US$1b |
| Dec 31 2017 | US$290k | n/a | US$1b |
Compensatie versus markt: De totale vergoeding ($USD 15.98M ) Adam } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 12.64M ).
Compensatie versus inkomsten: De vergoeding van Adam is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Adam Schechter (59 yo)
5yrs
Tenure
US$15,979,355
Compensatie
Mr. Adam H. Schechter serves as the President, CEO & Chairman of Laboratory Corporation of America Holdings. Mr. Adam serves as President & Chief Executive Officer at Labcorp Holdings Inc. since November...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 5yrs | US$15.98m | 0.10% $ 21.1m | |
| CFO & Executive VP | 10.4yrs | US$4.96m | 0.037% $ 7.5m | |
| Executive VP | 1.5yrs | US$3.80m | 0.0060% $ 1.2m | |
| EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer | 1.5yrs | US$3.48m | 0.033% $ 6.7m | |
| Executive VP & Chief Human Resources Officer | 1.6yrs | US$2.56m | 0.00035% $ 70.6k | |
| Senior VP & Chief Accounting Officer | 5.6yrs | geen gegevens | 0.0025% $ 504.5k | |
| Executive VP and Chief Information & Technology Officer | less than a year | geen gegevens | 0.0032% $ 643.8k | |
| Vice President of Investor Relations | no data | geen gegevens | geen gegevens | |
| Executive VP | 5.8yrs | geen gegevens | 0.0044% $ 886.0k | |
| Executive VP & Chief Marketing Officer | 4.7yrs | geen gegevens | 0.0047% $ 958.6k | |
| Enterprise Chief Scientific Officer & Senior VP | no data | geen gegevens | geen gegevens | |
| Chief Medical Officer | 3.8yrs | geen gegevens | geen gegevens |
4.3yrs
Gemiddelde duur
59yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van LH wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.3 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 11.6yrs | US$15.98m | 0.10% $ 21.1m | |
| Independent Director | 11.8yrs | US$357.87k | 0.014% $ 2.9m | |
| Independent Director | 18.5yrs | US$340.73k | 0.017% $ 3.4m | |
| Lead Independent Director | 10.9yrs | US$375.73k | 0.014% $ 2.9m | |
| Independent Director | 8.8yrs | US$341.44k | 0.010% $ 2.1m | |
| Independent Director | 10.6yrs | US$330.01k | 0.010% $ 2.1m | |
| Independent Director | 4.9yrs | US$344.30k | 0.0043% $ 873.9k | |
| Independent Director | 1.4yrs | US$208.42k | 0.00087% $ 175.6k | |
| Independent Director | 3.7yrs | US$330.01k | 0.0027% $ 553.0k | |
| Independent Director | 2.1yrs | US$330.01k | 0.0016% $ 318.9k |
9.7yrs
Gemiddelde duur
60yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van LH wordt beschouwd als ervaren (gemiddelde ambtstermijn 9.7 jaar).